Meeting
2024 ASCO Gastrointestinal Cancers Symposium
Does routine clinical assessment of older adults with gastroesophageal cancer tell the whole story?
Authors
Meghan Connors
Fox Chase Cancer Center, Philadelphia, PA
Meghan Connors , Caitlin R. Meeker , Elizabeth Handorf , Kelly A. Filchner , Mohamedtaki Abdulaziz Tejani , Grant Richard Williams , Arthur Winer , Sukeshi Patel Arora , Namrata Vijayvergia , Efrat Dotan
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Cancers of the Esophagus and Stomach and Other Gastrointestinal Cancers
Track
Esophageal and Gastric Cancer,Other GI Cancer
Sub Track
Quality of Care/Quality Improvement
Citation
J Clin Oncol 42, 2024 (suppl 3; abstr 297)
DOI
10.1200/JCO.2024.42.3_suppl.297
Abstract #
297
Poster Bd #
D17
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Regorafenib in older adults with metastatic colorectal cancer: A multi-center, single arm phase II trial.
First Author: Nabeel Badri
Poster
2020 ASCO Virtual Scientific Program
External validation of two predictive scores of chemotherapy toxicities among older patients with solid cancer, from ELCAPA prospective cohort.
First Author: Maxime Frelaut
Poster
2017 ASCO Quality Care Symposium
No news, bad news? A deeper examination of the correlation between patient functional status and level of postoperative telephone communication with the surgical team.
First Author: Adrienne Nicole Hawkins Baksh
Poster
2024 ASCO Annual Meeting
AGITG MONARCC: A randomized phase 2 study of panitumumab monotherapy and panitumumab (pan) plus 5 fluorouracil (FU) as first-line therapy for RAS and BRAF wild type metastatic colorectal cancer—A trial by the Australasian Gastro-Intestinal Trials Group (AGITG).
First Author: Matthew E. Burge